Literature DB >> 14620867

Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.

Ted A Broome1, Murray P Brown, Ronald R Gronwall, Matthew F Casey, Kelly A Meritt.   

Abstract

Six healthy adult horses (5 mares and 1 stallion) were given a single dose of acetylsalicylic acid (ASA), 20 mg/kg of body weight, by intravenous (IV), rectal, and intragastric (IG) routes. Serial blood samples were collected via jugular venipuncture over a 36-h period, and plasma ASA and salicylic acid (SA) concentrations were determined by high-performance liquid chromatography. After IV administration, the mean elimination rate constant of ASA (+/- the standard error of the mean) was 1.32 +/- 0.09 h(-1), the mean elimination half-life was 0.53 +/- 0.04 h, the area under the plasma concentration-versus-time curve (AUC) was 2555 +/- 98 microg x min/mL, the plasma clearance was 472 +/- 18.9 mL/h/kg, and the volume of distribution at steady state was 0.22 +/- 0.01 L/kg. After rectal administration, the plasma concentration of ASA peaked at 5.05 +/- 0.80 microg/mL at 0.33 h, then decreased to undetectable levels by 4 h; the plasma concentration of SA peaked at 17.39 +/- 5.46 microg/mL at 2 h, then decreased to 1.92 +/- 0.25 microg/mL by 36 h. After rectal administration, the AUC for ASA was 439.4 +/- 94.55 microg x min/mL and the bioavailability was 0.17 +/- 0.037. After IG administration, the plasma concentration of ASA peaked at 1.26 +/- 0.10 microg/mL at 0.67 h, then declined to 0.37 +/- 0.37 microg/mL by 36 h; the plasma concentration of SA peaked at 23.90 +/- 4.94 microg/mL at 4 h and decreased to 0.85 +/- 0.31 microg/mL by 36 h. After IG administration, the AUC for ASA was 146.70 +/- 24.90 microg x min/mL and the bioavailability was 0.059 +/- 0.013. Administration of a single rectal dose of ASA of 20 mg/kg to horses results in higher peak plasma ASA concentrations and greater bioavailability than the same dose given IG. Plasma ASA concentrations after rectal administration should be sufficient to inhibit platelet thromboxane production, and doses lower than those suggested for IG administration may be adequate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620867      PMCID: PMC280715     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  25 in total

1.  Sites of organic acid production and absorption in the equine gastrointestinal tract.

Authors:  R A Argenzio; M Southworth; C E Stevens
Journal:  Am J Physiol       Date:  1974-05

2.  Influence of food on aspirin absorption from tablets and buffered solutions.

Authors:  W D Mason; N Winer
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

Review 3.  The effect of food on drug bioavailability.

Authors:  R D Toothaker; P G Welling
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

4.  Clinical pharmacology of salicylates.

Authors:  L E Davis
Journal:  J Am Vet Med Assoc       Date:  1980-01-01       Impact factor: 1.936

5.  Bioavailability of rectal aspirin in neurosurgical patients.

Authors:  J Kanto; J Klossner; R Mäntylä; T Yrjänä
Journal:  Acta Anaesthesiol Scand       Date:  1981-02       Impact factor: 2.105

6.  Effect of oral administration of acetylsalicylic acid on haemostasis in the horse.

Authors:  O Trujillo; A Rios; R Maldonado; W Rudolph
Journal:  Equine Vet J       Date:  1981-07       Impact factor: 2.888

7.  Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse.

Authors:  M Sullivan; D H Snow
Journal:  Vet Rec       Date:  1982-06-12       Impact factor: 2.695

8.  Antithrombotic therapy. Rationale and application.

Authors:  D Deykin
Journal:  Postgrad Med       Date:  1979-01       Impact factor: 3.840

9.  Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse.

Authors:  P Lees; A J Higgins
Journal:  Equine Vet J       Date:  1985-03       Impact factor: 2.888

10.  Measurement and pharmacokinetics of acetylsalicylic acid by a novel high performance liquid chromatographic assay.

Authors:  B E Cham; L Ross-Lee; F Bochner; D M Imhoff
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

View more
  4 in total

1.  Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers.

Authors:  J Nagelschmitz; M Blunck; J Kraetzschmar; M Ludwig; G Wensing; T Hohlfeld
Journal:  Clin Pharmacol       Date:  2014-03-19

2.  A cross-sectional study of the availability and pharmacist's knowledge of nano-pharmaceutical drugs in Palestinian hospitals.

Authors:  Mohyeddin Assali; Ali Shakaa; Sabaa Abu-Hejleh; Reham Abu-Omar; Nareman Karajeh; Nawal Ajory; Saed Zyoud; Waleed Sweileh
Journal:  BMC Health Serv Res       Date:  2018-04-05       Impact factor: 2.655

3.  Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.

Authors:  Kathrin Buntenkötter; Maren Osmers; Ina Schenk; Wilhelm Schänzer; Marc Machnik; Michael Düe; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2017-01-19       Impact factor: 2.741

4.  Synovial distribution of "systemically" administered acetylsalicylic acid in the isolated perfused equine distal limb.

Authors:  Maren Friebe; Stephan Schumacher; Jessica Stahl; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2013-03-26       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.